Balance Sheet
Cash Flow Statement
AmortizationAmortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GNMSF) Change in Intangibles (2023 - 2025)

Historic Change in Intangibles for Genmab A (GNMSF) over the last 3 years, with Q1 2025 value amounting to -$18.0 million.

  • Genmab A's Change in Intangibles changed N/A to -$18.0 million in Q1 2025 from the same period last year, while for Dec 2025 it was -$18.0 million, marking a year-over-year change of. This contributed to the annual value of -$18.0 million for FY2025, which is 588.24% down from last year.
  • As of Q1 2025, Genmab A's Change in Intangibles stood at -$18.0 million.
  • Over the past 5 years, Genmab A's Change in Intangibles peaked at -$1.0 million during Q4 2023, and registered a low of -$18.0 million during Q1 2025.
  • In the last 3 years, Genmab A's Change in Intangibles had a median value of -$9.5 million in 2024 and averaged -$9.5 million.
  • Data for Genmab A's Change in Intangibles shows a peak YoY increase of 160000.0% (in 2024) and a maximum YoY decrease of 160000.0% (in 2024) over the last 5 years.
  • Over the past 3 years, Genmab A's Change in Intangibles (Quarter) stood at -$1.0 million in 2023, then plummeted by 1600.0% to -$17.0 million in 2024, then decreased by 5.88% to -$18.0 million in 2025.
  • Its last three reported values are -$18.0 million in Q1 2025, -$17.0 million for Q4 2024, and -$2.0 million during Q3 2024.